AAAAAA

   
Results: 1-18 |
Results: 18

Authors: TAHVANAINEN E SYVANNE M FRICK MH MURTOMAKIREPO S ANTIKAINEN M KESANIEMI YA KAUMA H PASTERNAK A TASKINEN MR EHNHOLM C
Citation: E. Tahvanainen et al., ASSOCIATION OF VARIATION IN HEPATIC LIPASE ACTIVITY WITH PROMOTER VARIATION IN THE HEPATIC LIPASE GENE, The Journal of clinical investigation, 101(5), 1998, pp. 956-960

Authors: HUMPHRIES SE LUONG LA TALMUD PJ FRICK MH KESANIEMI YA PASTERNACK A TASKINEN MR SYVANNE M
Citation: Se. Humphries et al., THE 5A 6A POLYMORPHISM IN THE PROMOTER OF THE STROMELYSIN-1 (MMP-3) GENE PREDICTS PROGRESSION OF ANGIOGRAPHICALLY DETERMINED CORONARY-ARTERY DISEASE IN MEN IN THE LOCAT GEMFIBROZIL STUDY/, Atherosclerosis (Amsterdam), 139(1), 1998, pp. 49-56

Authors: SYVANNE M NIEMINEN MS FRICK MH KAUMA H MAJAHALME S VIRTANEN V KESANIEMI YA PASTERNACK A EHNHOLM C TASKINEN MR
Citation: M. Syvanne et al., ASSOCIATIONS BETWEEN LIPOPROTEINS AND THE PROGRESSION OF CORONARY ANDVEIN-GRAFT ATHEROSCLEROSIS IN A CONTROLLED TRIAL WITH GEMFIBROZIL IN MEN WITH LOW BASE-LINE LEVELS OF HDL CHOLESTEROL, Circulation, 98(19), 1998, pp. 1993-1999

Authors: SYVANNE M TASKINEN MR NIEMINEN MS MANNINEN V KESANIEMI YA PASTERNACK A NAWROCKI JW HABER H FRICK MH
Citation: M. Syvanne et al., A STUDY TO DETERMINE THE RESPONSE OF CORONARY ATHEROSCLEROSIS TO RAISING LOW HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL WITH A FIBRIC-ACID DERIVATIVE IN MEN AFTER CORONARY-BYPASS SURGERY - THE RATIONALE, DESIGN, ANDBASE-LINE CHARACTERISTICS OF THE LOCAT STUDY, Controlled clinical trials, 18(1), 1997, pp. 93-119

Authors: FRICK MH SYVANNE M NIEMINEN MS KAUMA H MAJAHALME S VIRTANEN V KESANIEMI A PASTERNACK A TASKINEN MR
Citation: Mh. Frick et al., PREVENTION OF THE ANGIOGRAPHIC PROGRESSION OF CORONARY AND VEIN-GRAFTATHEROSCLEROSIS BY GEMFIBROZIL AFTER CORONARY-BYPASS SURGERY IN MEN WITH LOW-LEVELS OF HDL CHOLESTEROL, Circulation, 96(7), 1997, pp. 2137-2143

Authors: ANTIKAINEN M MURTOMAKI S SYVANNE M PAHLMAN R TAHVANAINEN E JAUHIAINEN M FRICK MH EHNHOLM C
Citation: M. Antikainen et al., THE GLN-ARG191 POLYMORPHISM OF THE HUMAN PARAOXONASE GENE (HUMPONA) IS NOT ASSOCIATED WITH THE RISK OF CORONARY-ARTERY DISEASE IN FINNS, The Journal of clinical investigation, 98(4), 1996, pp. 883-885

Authors: MANTTARI M TENKANEN L MANNINEN V ALIKOSKI T FRICK MH
Citation: M. Manttari et al., ANTIHYPERTENSIVE THERAPY IN DYSLIPIDEMIC MEN - EFFECTS ON CORONARY HEART-DISEASE INCIDENCE AND TOTAL MORTALITY, Hypertension, 25(1), 1995, pp. 47-52

Authors: FRICK MH OPIE LH PAPP JG
Citation: Mh. Frick et al., CALCIUM SENSITIZATION VIA TROPONIN-C - A NEW APPROACH FOR THE TREATMENT OF HEART-FAILURE - PROCEEDINGS OF AN INTERNATIONAL-SYMPOSIUM IN ASSOCIATION WITH THE JOINT XIITH WORLD CONGRESS OF CARDIOLOGY AND XVITH CONGRESS OF THE EUROPEAN-SOCIETY-OF-CARDIOLOGY, SEPTEMBER 10, 1994, BERLIN, GERMANY - PREFACE, Journal of cardiovascular pharmacology, 26, 1995, pp. 5-6

Authors: HUTTUNEN JK HEINONEN P MANNINEN V KOSKINEN P HAKULINEN T TEPPO L MANTTARI M FRICK MH
Citation: Jk. Huttunen et al., THE HELSINKI-HEART-STUDY - AN 8.5-YEAR SAFETY AND MORTALITY FOLLOW-UP, Journal of internal medicine, 235(1), 1994, pp. 31-39

Authors: HEINONEN OP HUTTUNEN JK MANNINEN V MANTTARI M KOSKINEN P TENKANEN L FRICK MH
Citation: Op. Heinonen et al., THE HELSINKI-HEART-STUDY - CORONARY HEART-DISEASE INCIDENCE DURING ANEXTENDED FOLLOW-UP, Journal of internal medicine, 235(1), 1994, pp. 41-49

Authors: REMME WJ KRAYENBUHL HP BAUMANN G FRICK MH HAEHL M NEHMIZ G BAIKER W
Citation: Wj. Remme et al., LONG-TERM EFFICACY AND SAFETY OF PIMOBENDAN IN MODERATE HEART-FAILURE- A DOUBLE-BLIND PARALLEL 6-MONTH COMPARISON WITH ENALAPRIL, European heart journal, 15(7), 1994, pp. 947-956

Authors: MANTTARI M MANNINEN V HUTTUNEN JK PALOSUO T ENHOLM C HEINONEN OP FRICK MH
Citation: M. Manttari et al., SERUM FERRITIN AND CERULOPLASMIN AS CORONARY RISK-FACTORS, European heart journal, 15(12), 1994, pp. 1599-1603

Authors: HAUTANEN A MANTTARI M MANNINEN V TENKANEN L HUTTUNEN JK FRICK MH ADLERCREUTZ H
Citation: A. Hautanen et al., ADRENAL ANDROGENS AND TESTOSTERONE AS CORONARY RISK-FACTORS IN THE HELSINKI HEART-STUDY, Atherosclerosis, 105(2), 1994, pp. 191-200

Authors: HAUTANEN A MANTTARI M KUPARI M SARNA S MANNINEN V FRICK MH ADLERCREUTZ H
Citation: A. Hautanen et al., CIGARETTE-SMOKING IS ASSOCIATED WITH ELEVATED ADRENAL ANDROGEN RESPONSE TO ADRENOCORTICOTROPIN, Journal of steroid biochemistry and molecular biology, 46(2), 1993, pp. 245-251

Authors: FRICK MH
Citation: Mh. Frick, CHOLESTEROL AND CORONARIES - A CITATION-CLASSIC COMMENTARY ON HELSINKI HEART-STUDY - PRIMARY-PREVENTION TRIAL WITH GEMFIBROZIL IN MIDDLE-AGED MEN WITH DYSLIPIDEMIA - SAFETY OF TREATMENT, CHANGES IN RISK-FACTORS, AND INCIDENCE OF CORONARY HEART-DISEASE BY FRICK,M.H., ELO,O., HAAPA,K., HEINONEN,O.P., HEINSALMI,P., HELO,P., HUTTUNEN,J.K., KAITANIEMI,P., KOSKINEN,P., MANNINEN,V., MAENPAA,H., MALKONEN,M., MANTTARI,M., NOROLA,S., PASTERNACK,A., PIKKARAINEN,J., ROMO,M.,, Current contents. Clinical medicine, (38), 1993, pp. 8-8

Authors: VALTONEN V MANNINEN V FRICK MH
Citation: V. Valtonen et al., 10TH PAAVO-NURMI-SYMPOSIUM - ROLE OF INFECTION AND IN FLAMMATION IN VASCULAR-DISEASE - 27-29 AUGUST 1992, HELSINKI, FINLAND - FOREWORD, European heart journal, 14, 1993, pp. 1-1

Authors: MANTTARI M JAVELA K KOSKINEN P PIKKARAINEN J MANNINEN V HUTTUNEN JK FRICK MH
Citation: M. Manttari et al., SEASONAL-VARIATION IN HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL, Atherosclerosis, 100(2), 1993, pp. 257-265

Authors: MANTTARI M MANNINEN V HUTTUNEN JK HEINONEN OP FRICK MH
Citation: M. Manttari et al., SERUM FERRITIN AND CERULOPLASMIN AS CORONARY RISK-FACTORS - A NESTED CASE-CONTROL STUDY IN THE HELSINKI HEART-STUDY POPULATION, Circulation, 88(4), 1993, pp. 70-70
Risultati: 1-18 |